Green tea, an unfermented tea-plant leaf drunk brewed or as matcha or taken as an extract, is discussed as a longevity habit. Trials show it slightly lowers blood pressure and “bad” cholesterol; population studies link regular drinking to fewer deaths and strokes but cannot rule out healthier lifestyles. High-dose extracts, especially taken fasting, can injure the liver in a minority, and green tea can weaken several heart and blood-pressure medicines. (Full Review)
| Marker | Target | Why |
|---|---|---|
| ALT | About 7–56 U/L | Extract safety check |
| AST | About 10–40 U/L | Extract safety check alongside ALT |
| Ferritin | About 24–336 ng/mL (men), 11–307 ng/mL (women) | Iron-absorption effect |
| Blood pressure | No established target; change from own baseline | Expected small fall |
| LDL cholesterol | No established target; change from own baseline | Expected small fall; detects reduced statin effect |
| Fasting glucose | About 70–99 mg/dL | Expected slight fall |
| INR (warfarin users only) | Stable within the prescriber's range | A fall changes anticoagulant dosing |
Cadence: Brewed tea at usual intakes: no laboratory monitoring beyond routine care. Extracts: ALT, AST and ferritin at baseline; ALT and AST at 1, 3 and 6 months, then every 6–12 months. Ferritin every 6–12 months. Fasting glucose and LDL at baseline; blood pressure, LDL or INR at baseline for users of nadolol, lisinopril, statins, raloxifene or warfarin. Blood pressure and LDL 4–8 weeks after starting, then at routine intervals. Dark urine, jaundice or abdominal pain prompts immediate testing.